This result shows that the loss of TMEM5 function in the WWS patients is not caused by a cellular processing defect, but rather directly affects the catalytic domain and abrogates the proposed xylose glycosyltransferase activity. The gene discussed is RXYLT1; the disease is muscular dystrophy-dystroglycanopathy, type A.